

Glee Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.69 M
- Revenue Growth 9.73%
- Profit Growth 64.89%
- Ebitda 86.57%
- Net Worth 106.92%
- Total Assets 100.43%
About Glee Biotech
Glee Biotech Limited (GBL) is a Public Limited Indian Non-Government Company incorporated in India on 03 March 2020 (Five years and two months 11 days old ). Its registered office is in North West Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹4.69 M.
Rachna Bhatia, Raghav Bhatia, Kiran Bhatia, and One other member serve as directors at the Company.
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33100DL2020PLC362536
- Company No.
362536
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
03 Mar 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Glee Biotech Limited offer?
Glee Biotech Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Anti Allergic Drug, Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs.
Who are the key members and board of directors at Glee Biotech?
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rachna Bhatia ![]() | Director | 03-Mar-2020 | Current |
Raghav Bhatia ![]() | Director | 03-Mar-2020 | Current |
Kiran Bhatia ![]() | Director | 08-Dec-2020 | Current |
Vikas Khatri | Director | Current |
Financial Performance of Glee Biotech.
Glee Biotech Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.73% increase. The company also saw a substantial improvement in profitability, with a 64.89% increase in profit. The company's net worth Soared by an impressive increase of 106.92%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Glee Biotech?
In 2023, Glee Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Phamilymed Private Limited
Raghav Bhatia is a mutual person
Charges (Loans)
₹4.69 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.47 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
23 May 2023 | Hdfc Bank Limited | ₹0.95 M | Open |
06 Sep 2022 | Hdfc Bank Limited | ₹3.73 M | Open |
How Many Employees Work at Glee Biotech?
Unlock and access historical data on people associated with Glee Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Glee Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glee Biotech's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Glee Biotech
Recent activity within the organization
- Annual General Meeting
Glee Biotech Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.95 M with Charge ID 100726415 was registered on 23 May 2023.
- Balance Sheet
Glee Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
- Charges
A charge with Hdfc Bank Limited amounted to Rs. 3.73 M with Charge ID 100649046 was registered on 06 Sep 2022.
- Director Appointment
Kiran Bhatia was appointed as a Director was appointed as a Director on 08 Dec 2020 & has been associated with this company since 4 years 5 months .
- Director Appointment
Rachna Bhatia was appointed as a Director was appointed as a Director on 03 Mar 2020 & has been associated with this company since 5 years 2 months .
Frequently asked questions
What is the Incorporation or founding date of Glee Biotech Limited?
Glee Biotech Limited was incorporated on 03 Mar 2020.
What is authorized share capital and paid-up capital of Glee Biotech Limited?
The authorized share capital of Glee Biotech Limited is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.
Who are the current board members & directors of Glee Biotech Limited?
Currently 4 directors are associated with Glee Biotech Limited.
- Rachna Bhatia
- Raghav Bhatia
- Kiran Bhatia
- Vikas Khatri
What is the registered address of Glee Biotech Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Glee Biotech Limited is 301-302 Block Pocket B-4 Sector-8, Rohini India, New Delhi, 110085.
What is the corporate identification number (CIN) and company number of Glee Biotech Limited?
The corporate identification number (CIN) of Glee Biotech Limited is U33100DL2020PLC362536 and the company number is 362536 as per Ministry of Corporate Affairs (MCA).
What is the official website of Glee Biotech Limited?
The Official website of Glee Biotech Limited is https://www.gleebiotech.com
What has been the recent revenue trend for Glee Biotech Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Glee Biotech Limited has risen by 9.73%.
What change has been observed in the net worth of Glee Biotech Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Glee Biotech Limited has experienced an upsurge of 106.92%.
What are the total open charges for Glee Biotech Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Glee Biotech Limited amount to ₹ 4.69 M.
When was the last Balance Sheet of Glee Biotech Limited filed with the ROC?
The most recent Balance Sheet for Glee Biotech Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
AK
Anil KumarDirector
Similar Companies Based on Drug Formulation & Development
- Mylan Laboratories Limited Hyderabad, Telangana, India
- Sun Pharma Laboratories Limited Vadodara, Gujarat, India
- Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
- Lupin Limited Mumbai, Maharashtra, India
- Alkem Laboratories Limited Mumbai, Maharashtra, India
- Hetero Labs Limited Rangareddy, Telangana, India
- Aurobindo Pharma Ltd Hyderabad, Telangana, India
- Cipla Limited Mumbai, Maharashtra, India